SAFETY AND PHARMACOKINETICS
Clinical trials for SAFETY AND PHARMACOKINETICS explained in plain language.
Never miss a new study
Get alerted when new SAFETY AND PHARMACOKINETICS trials appear
Sign up with your email to follow new studies for SAFETY AND PHARMACOKINETICS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could preterm babies safely get fewer antibiotics?
Knowledge-focused Not yet recruitingThis study looks at whether preterm infants in the NICU can safely stop taking the antibiotic ampicillin after 24 to 36 hours instead of the usual 48 hours. Researchers will measure drug levels in the blood and monitor the babies for any problems. The goal is to see if a shorter …
Matched conditions: SAFETY AND PHARMACOKINETICS
Phase: PHASE1, PHASE2 • Sponsor: Duke University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
New russian drug fluorothiazinone enters first human safety tests
Knowledge-focused Not yet recruitingThis early-stage trial will test the safety of a new drug called fluorothiazinone in 70 healthy adults aged 18 to 45. Participants will receive either a single dose or a short course of the drug or a placebo. The main goal is to check for side effects and how the drug moves throu…
Matched conditions: SAFETY AND PHARMACOKINETICS
Phase: PHASE1 • Sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC